CTRI/2010/091/000509
Not Applicable
Phase 3
Clinical evaluation of immunogenicity and safety of Purified Chick Embryo Cell Culture (PCEC) Rabies Vaccine administered intradermally using Updated Thai Red Cross Regimen in healthy volunteers
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: Z23- Encounter for immunization
- Sponsor
- Cadila Healthcare Ltd
- Enrollment
- 36
- Status
- Not Applicable
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Healthy adult volunteers of either gender aged between 18\-55 years.
- •2\.If female, not pregnant or lactating at the time of enrolment and not planning pregnancy during the vaccination period.
- •3\.Subjects likely to be available for all visits during follow\-up period.
- •4\.Willing to sign Informed consent.
Exclusion Criteria
- •1\.Pregnancy \& Lactation.
- •2\.Subject has received any type of rabies vaccination in the past.
- •3\.Subject has received any dose of rabies immunoglobulin (human/equine) in the past.
- •4\.Subject suffering from any other illness of whatsoever nature
- •5\.Subject is on steroids or any other immunosuppressants or is known to be HIV positive.
- •6\.Subject is planning for surgery in the next 3 months.
- •7\.Subject is on concomitant antimalarials.
- •8\.Subject with history of allergy to any ingredient of the vaccine.
- •9\.Subject not likely to be available for follow\-up.
- •10\.Participation in another clinical trial in the past 3 months.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Protection and Safety of rabies vaccine when administered intradermallyCTRI/2012/06/002720I70
Completed
Phase 3
Safety and immunogenicity of rabies vaccines in animal bite cases administered using new one week intradermal regimeCTRI/2012/12/003230Department of Community Medicine Kempegowda Institute of Medical Sciences KIMS80
Not yet recruiting
Phase 4
Assessment of the protection offered by single dose of COVID-19 vaccines in individuals previously affected with COVID-19CTRI/2021/10/037099Indian Council of Medical research ICMR
Not yet recruiting
Phase 3
Phase III study of the Cuban vaccine candidate VCN7-T in patients from 1 to 18 years of age at risk of pneumococcal disease in HavanaPneumococcal diseasesVCN7-TPneumococcal InfectionsStreptococcal InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsRPCEC00000432Finlay Vaccine Institute (FVI)
Active, not recruiting
Phase 1
A study to Evaluate Immunogenicity, Safety and Tolerability of a Single Dose of ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2COVID-19 diseaseMedDRA version: 23.1Level: PTClassification code 10084457Term: COVID-19 immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2021-005504-36-DKBavarian Nordic A/S4,000